Home › Venous Thromboembolism › Massachusetts › Boston
Venous Thromboembolism clinical trials in Boston, MA
7 studies for Venous Thromboembolism are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
Recruiting
- Brigham and Women's Hospital, Boston
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
RecruitingPhase 3
- Brigham and Women's Hospital, Boston
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
RecruitingObservational study
- Massachusetts General Hospital, Boston
Statins to Prevent Cancer Associated Blood Clots
RecruitingPhase 4
- Beth Isreal Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Apixaban in Thrombocytopenia
RecruitingEarly phase 1
- Beth Israel Deaconess Medical Center, Boston
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Beth Israel Deaconess Medical Center, Boston
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RecruitingEarly phase 1
- Massachusetts General Hospital, Boston
Venous Thromboembolism trials in other cities
- New York City, NY6 studies
- Houston, TX4 studies
- Dallas, TX4 studies
- Cleveland, OH3 studies
- Miami, FL3 studies
- New Haven, CT3 studies
- Jacksonville, FL3 studies
- Philadelphia, PA3 studies
- Tampa, FL3 studies
- Sarasota, FL3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.